Back to Search
Start Over
Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study
- Source :
- Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
- Publication Year :
- 2022
- Publisher :
- BMJ Publishing Group, 2022.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 20511426
- Volume :
- 10
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Journal for ImmunoTherapy of Cancer
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.14cae0105ca4a77863badc972ff7d01
- Document Type :
- article
- Full Text :
- https://doi.org/10.1136/jitc-2021-003777